|
Overview of Structural Genomics: Landscape, Premises, and Current Direction |
|
|
1 | (18) |
|
|
|
|
|
|
The Landscape of Sequence Genomics |
|
|
1 | (2) |
|
Premises of Structural Genomics |
|
|
3 | (6) |
|
|
3 | (1) |
|
|
3 | (2) |
|
Representation of the Protein Fold Space |
|
|
5 | (2) |
|
Fold and Functional Space Coverage |
|
|
7 | (1) |
|
Family and Fold Space Coverage |
|
|
7 | (2) |
|
Functional Space Coverage |
|
|
9 | (1) |
|
|
9 | (5) |
|
Metrics and Lessons Learned from PSI Pilot Phase |
|
|
14 | (2) |
|
|
16 | (3) |
|
|
16 | (1) |
|
|
17 | (2) |
|
Purifying Protein for Structural Biology |
|
|
19 | (10) |
|
|
|
19 | (1) |
|
|
19 | (4) |
|
Escherichia coli: The Consensus Expression System |
|
|
20 | (1) |
|
Insufficient Protein Expression and Solubility: The Bane of Structural Biologists |
|
|
20 | (3) |
|
Expression of Eukaryotic Proteins |
|
|
23 | (1) |
|
|
24 | (1) |
|
|
25 | (4) |
|
|
26 | (3) |
|
Protein Crystallization: Automation, Robotization, and Miniaturization |
|
|
29 | (20) |
|
|
|
30 | (1) |
|
|
30 | (1) |
|
The Search for Crystallization Conditions (Screening) |
|
|
30 | (1) |
|
Automation and Miniaturisation of Screening Procedures |
|
|
31 | (4) |
|
|
31 | (1) |
|
The Effect of Different Oils |
|
|
32 | (1) |
|
|
33 | (1) |
|
|
33 | (1) |
|
|
34 | (1) |
|
Imaging and Monitoring of Crystallization Trials |
|
|
35 | (1) |
|
Genomics/Proteomics Projects: Current State of the Art |
|
|
35 | (1) |
|
Automation of Optimisation Experiments Based on the Fundamental Principles of Crystallization |
|
|
36 | (4) |
|
Utilisation of Crystallization Phase Diagrams |
|
|
36 | (2) |
|
Dynamic Separation of Nucleation and Growth |
|
|
38 | (2) |
|
Other Automated Means to Control the Crystallization Environment |
|
|
40 | (2) |
|
Solubility as a Function of Temperature |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
40 | (2) |
|
|
42 | (1) |
|
Automation and Miniaturisation of the Crystallization of Membrane Proteins |
|
|
42 | (1) |
|
|
42 | (1) |
|
Crystallization Under Oil |
|
|
43 | (1) |
|
Key Issues and Next Steps |
|
|
43 | (6) |
|
|
44 | (5) |
|
NMR Spectroscopy in Structural Genomics |
|
|
49 | (12) |
|
|
|
|
|
49 | (1) |
|
|
50 | (3) |
|
Recent Development of NMR Techniques for Structural Proteomics |
|
|
53 | (4) |
|
|
54 | (1) |
|
Cryogenic/Chilled Probe Technology |
|
|
54 | (1) |
|
Transverse Relaxation Optimization Spectroscopy (TROSY) |
|
|
54 | (1) |
|
Residual Dipolar Coupling (RDC) |
|
|
55 | (1) |
|
|
55 | (1) |
|
Isotope Labeling Techniques |
|
|
56 | (1) |
|
Isotope Labeling of Protein |
|
|
56 | (1) |
|
Selective Protonation of Methyl Group and Segmental Labeling |
|
|
56 | (1) |
|
|
57 | (1) |
|
NMR-Based Functional Genomics |
|
|
57 | (4) |
|
|
58 | (3) |
|
High Throughput Protein Crystallography |
|
|
61 | (44) |
|
|
|
62 | (6) |
|
|
62 | (1) |
|
Choosing Crystallography for High Throughput Structure Determination |
|
|
62 | (2) |
|
|
64 | (1) |
|
Definition of High Throughput Protein Crystallography |
|
|
65 | (1) |
|
High Throughput vs. Low Throughput |
|
|
65 | (1) |
|
|
65 | (3) |
|
|
68 | (1) |
|
Methods of High Throughput Protein Crystallography |
|
|
68 | (37) |
|
|
68 | (1) |
|
Processes Involving Crystal Manipulation |
|
|
69 | (6) |
|
Selection and Harvesting of Crystals |
|
|
75 | (1) |
|
Soaking and Derivatization of Crystals |
|
|
75 | (1) |
|
Cryo-Protection and Loop Mounting |
|
|
76 | (1) |
|
|
77 | (1) |
|
|
77 | (1) |
|
High Throughput Considerations |
|
|
77 | (2) |
|
Data Collection as a Multi-Level Decision Process |
|
|
79 | (1) |
|
Initial Assessment of Crystal Quality and Indexing |
|
|
79 | (2) |
|
Data Collection Strategies for Phasing |
|
|
81 | (1) |
|
Data Collection for High Resolution Structures |
|
|
82 | (1) |
|
Single Anomalous Diffraction Data and SAD from Sulfur |
|
|
82 | (2) |
|
Multiple Anomalous Diffraction Data |
|
|
84 | (1) |
|
|
85 | (1) |
|
Crystallographic Computing |
|
|
85 | (1) |
|
Data Reduction and Scaling |
|
|
85 | (1) |
|
|
86 | (1) |
|
|
87 | (2) |
|
Initial Phase Calculation |
|
|
89 | (1) |
|
Density Modification Techniques |
|
|
89 | (16) |
|
From Sequence to Function |
|
|
105 | (4) |
|
|
|
105 | (1) |
|
Gene and Protein Sequence Databases |
|
|
106 | (1) |
|
Sequence Comparison Methods |
|
|
107 | (1) |
|
|
107 | (2) |
|
|
107 | (2) |
|
Comparative Modeling and Structural Proteomics |
|
|
109 | (28) |
|
|
|
|
|
109 | (2) |
|
Methods of Comparative Modeling |
|
|
111 | (5) |
|
Template Identification and Sequence Alignment |
|
|
112 | (1) |
|
|
113 | (2) |
|
|
115 | (1) |
|
Impact of Structural Genomics Targets on Modeling of Genome Sequences |
|
|
116 | (4) |
|
Purposes of Comparative Modeling from Structural Proteomics Targets |
|
|
120 | (9) |
|
Analysis of Sequence-Structure-Function Relationships of Orthologues and Paralogues of the Structural Proteomics Template |
|
|
120 | (5) |
|
Inhibitor Design and Off-Target Modeling |
|
|
125 | (1) |
|
Structure-Function Relationships of Mutations |
|
|
126 | (1) |
|
|
127 | (1) |
|
Modeling Used to Facilitate Structure Determination in Structural Proteomics |
|
|
127 | (2) |
|
|
129 | (1) |
|
|
130 | (7) |
|
|
130 | (1) |
|
|
131 | (6) |
|
|
137 | (26) |
|
|
|
|
The Importance of Protein Structure in the Postgenomic Era |
|
|
138 | (1) |
|
Overview of Protein Structure Prediction Methods |
|
|
138 | (1) |
|
Ab initio Structure Prediction: Historical Overview |
|
|
139 | (7) |
|
Continuous Space Reduced Models |
|
|
139 | (1) |
|
|
140 | (1) |
|
Ab initio Folding Using Secondary Structure Restraints |
|
|
141 | (1) |
|
Ab initio Folding Using Secondary and Tertiary Restraints |
|
|
141 | (1) |
|
Representative Conformational Search Methods |
|
|
142 | (1) |
|
ab initio Prediction Results in CASP3 and CASP4 |
|
|
143 | (3) |
|
The TOUCHSTONE ab initio Folding Algorithm |
|
|
146 | (8) |
|
|
146 | (2) |
|
Benchmarking on a Large Test Set |
|
|
148 | (1) |
|
Accuracy of Tertiary Contact and Secondary Structure Prediction |
|
|
149 | (1) |
|
A New Lattice Model for Tertiary Structure Prediction |
|
|
149 | (1) |
|
Selection of the Native Conformation |
|
|
150 | (1) |
|
Universal Similarity Measure for Comparing Protein Structures |
|
|
150 | (1) |
|
How Can One Select Native-Like Clusters? |
|
|
150 | (1) |
|
Relationship Between Cluster Population and Likelihood of Prediction Success |
|
|
151 | (1) |
|
Prediction of Tertiary Structure Using Residual Dipolar Coupling Information |
|
|
152 | (1) |
|
Benchmark Prediction of Tertiary Structure Using a Small Number of Exact Long Range Restraints (Specific Aim 7) |
|
|
152 | (1) |
|
Prediction of the Tertiary Structure All the Small Proteins in the M. genitalium Genome |
|
|
153 | (1) |
|
|
154 | (9) |
|
|
155 | (1) |
|
|
155 | (8) |
|
Determining Function from Structure |
|
|
163 | (22) |
|
|
|
163 | (2) |
|
Biochemical vs. Biological Function |
|
|
165 | (1) |
|
|
165 | (4) |
|
|
166 | (1) |
|
|
166 | (3) |
|
|
169 | (1) |
|
|
169 | (1) |
|
Detection of Binding Sites |
|
|
170 | (2) |
|
Identification of Cognate Ligands |
|
|
172 | (1) |
|
|
172 | (2) |
|
|
173 | (1) |
|
Physicochemical Properties |
|
|
173 | (1) |
|
|
173 | (1) |
|
|
174 | (1) |
|
Identification of Functionally Important Residues |
|
|
174 | (3) |
|
|
174 | (2) |
|
Identification of Residues with ``Unusual'' Properties |
|
|
176 | (1) |
|
|
177 | (3) |
|
Enzyme Catalytic Residues |
|
|
177 | (1) |
|
Automatically Generated Templates |
|
|
177 | (3) |
|
Protein--Protein Interaction Sites |
|
|
180 | (1) |
|
Determining the Biologically Relevant Unit |
|
|
180 | (1) |
|
|
181 | (4) |
|
|
182 | (1) |
|
|
182 | (3) |
|
Retrieval and Validation of Structural Information |
|
|
185 | (38) |
|
|
|
|
185 | (2) |
|
Primary Structural Databases |
|
|
187 | (4) |
|
|
187 | (2) |
|
|
189 | (1) |
|
Search Mechanisms and Front-Ends |
|
|
190 | (1) |
|
Secondary Structural Databases |
|
|
191 | (7) |
|
Structural Classification Databases |
|
|
191 | (2) |
|
Structurally Specialised Structural Databases |
|
|
193 | (1) |
|
Biologically Specialised Structural Databases |
|
|
194 | (2) |
|
|
196 | (2) |
|
|
198 | (16) |
|
|
198 | (1) |
|
Validation of Crystallographic Models |
|
|
199 | (1) |
|
|
200 | (1) |
|
|
200 | (2) |
|
|
202 | (1) |
|
|
202 | (3) |
|
|
205 | (1) |
|
|
205 | (3) |
|
Data Quality and Quantity |
|
|
208 | (1) |
|
Validation Using Experimental Data |
|
|
209 | (1) |
|
|
209 | (2) |
|
|
211 | (3) |
|
|
214 | (9) |
|
|
216 | (1) |
|
|
216 | (7) |
|
Problems in Computational Structural Genomics |
|
|
223 | (28) |
|
|
Introduction and Motivation |
|
|
224 | (1) |
|
|
224 | (1) |
|
Completing, Improving, and Correcting Experimental Structures |
|
|
225 | (4) |
|
Symmetry and Biological Unit |
|
|
226 | (1) |
|
Adding Missing or Zero-Occupancy Atoms, Resolving Uncertainties |
|
|
227 | (1) |
|
Detecting Errors: Energy Strain |
|
|
227 | (1) |
|
|
227 | (2) |
|
|
229 | (4) |
|
Predicting Local Model Reliability |
|
|
231 | (1) |
|
How Good are Homology Models? |
|
|
232 | (1) |
|
Annotating Protein Surface |
|
|
233 | (5) |
|
|
233 | (1) |
|
Structural Residue Pattern: Catalytic Triads |
|
|
234 | (1) |
|
Electrostatic Potential Indicates Binding Site for a Charged Ligand |
|
|
234 | (1) |
|
Binding Cleft Identification |
|
|
235 | (1) |
|
|
236 | (1) |
|
Protein-Protein Interaction Interface Prediction |
|
|
236 | (1) |
|
Surface Flexibility Views and Docking |
|
|
237 | (1) |
|
|
238 | (5) |
|
|
239 | (1) |
|
|
239 | (3) |
|
How Successful is Protein Docking? |
|
|
242 | (1) |
|
|
242 | (1) |
|
|
243 | (1) |
|
|
244 | (7) |
|
|
245 | (1) |
|
|
245 | (1) |
|
|
246 | (5) |
|
Applied Structural Genomics |
|
|
251 | (18) |
|
|
|
252 | (1) |
|
Completeness of Structural Space |
|
|
252 | (2) |
|
Public Structural Genomic Initiatives |
|
|
254 | (1) |
|
|
254 | (1) |
|
|
254 | (1) |
|
|
255 | (1) |
|
SGC (Canada and United Kingdom) |
|
|
255 | (1) |
|
Commercial Structural Genomics Operations |
|
|
255 | (2) |
|
Structural GenomiX (United States) |
|
|
256 | (1) |
|
|
256 | (1) |
|
Affinium Pharmaceuticals (Canada) |
|
|
256 | (1) |
|
Astex Technology (United Kingdom) |
|
|
257 | (1) |
|
Structure Guided Functional Validation |
|
|
257 | (1) |
|
Screening for Natural Ligands to Infer Function |
|
|
258 | (1) |
|
Screening for Enzymatic Activity |
|
|
258 | (1) |
|
|
259 | (1) |
|
Structure Based Drug Discovery |
|
|
259 | (1) |
|
Identification of Chemical Starting Points |
|
|
260 | (1) |
|
Validating Chemical Starting Points |
|
|
261 | (1) |
|
Protein--Protein Interactions |
|
|
261 | (1) |
|
Structure Based Selectivity Design |
|
|
262 | (1) |
|
|
262 | (1) |
|
Structural Mapping of Disease Causing Mutations |
|
|
263 | (1) |
|
|
263 | (1) |
|
|
263 | (1) |
|
|
264 | (1) |
|
|
264 | (1) |
|
Promises of Structural Genomics |
|
|
264 | (5) |
|
|
265 | (1) |
|
|
265 | (4) |
Index |
|
269 | |